Biobanks and scientists: supply and demand
Abstract The biobanks, providers of biospecimens, and the scientists, users of biological material, are both strategic actors in translational medicine but the communication about those two subjects seems to be delicate. Recently, biobank managers from US and Europe stressed the danger of underuse o...
Main Authors: | Angelo Virgilio Paradiso, Maria Grazia Daidone, Vincenzo Canzonieri, Alfredo Zito |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-018-1505-8 |
Similar Items
-
Current Status, Challenges, Policies, and Bioethics of Biobanks
by: Byunghak Kang, et al.
Published: (2013-12-01) -
Enriching Personalized Endometrial Cancer Research with the Harmonization of Biobanking Standards
by: Meera Adishesh, et al.
Published: (2019-11-01) -
Genomic and Genetic Disorders Biobank
by: Carmela Fusco, et al.
Published: (2015-03-01) -
Development of the Precision Link Biobank at Boston Children’s Hospital: Challenges and Opportunities
by: Florence T. Bourgeois, et al.
Published: (2017-12-01) -
The landscape of biobanks in Poland—characteristics of Polish biobanking units at the beginning of BBMRI.pl organization
by: Anna Chróścicka, et al.
Published: (2021-06-01)